Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted 23andMe authorization to sell tests for 33 pharmacogenetic variants directly to consumers.

The reports, the FDA said, provide consumers information about genetic variants that may be associated with their ability to metabolize some medications and help inform discussions with their healthcare providers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.